Market Trends of Oral Sleep Apnea Industry
This section covers the major market trends shaping the Oral Sleep Apnea Market according to our research experts:
Mandibular Advancement Devices Segment Expected to Witness Significant Growth
Mandibular advancement devices (MAD) are oral sleep apnea devices that adjust the jaw to expand the airways and assist in breathing during sleep. These devices are a non-invasive alternative to PAP devices and effectively treat mild to moderate sleep apnea. They are the primary treatment for sleep apnea, with mild to moderate severity in patients who feel uneasy with PAP devices. MAD devices offer the flexibility of being custom-made and offer desirable management of the problem. Several research publications have indicated the effectiveness of MADs in managing sleep apnea over the long term. For instance, a study published in the Journal of Craniomandibular & Sleep Practice in 2022 underlined the efficacy of MADs for managing mild to severe sleep apnea. These devices have shown positive results in reducing the apnea-hypopnea index (AHI) and sleep apnea-related symptoms, such as snoring, excessive daytime exhaustion, and unrefreshing sleep.
In addition, some key developments in mandibular advancement devices have further bolstered the market's growth. For instance, in July 2022, Glidewell launched its mandibular advancement device, the Silent Nite Sleep Appliance with Glidewell Hinge. The device is an extension of the Silent Nite brand, which dentists use to treat snoring and obstructive sleep apnea. Further, in September 2021, Vivos Therapeutics, Inc. received the USFDA's 510(k) market clearance for its mmRNA (modified mandibular repositioning nighttime appliance) oral appliance.
Therefore, owing to the abovementioned factors, such as efficacy, product launches, and regulatory approvals, the mandibular advancement devices segment is expected to witness significant growth over the forecast period.
North America Expected to Dominate the Oral Sleep Apnea Market
North America is expected to dominate the oral sleep apnea market owing to crucial factors, such as the high prevalence of sleep apnea, the vast geriatric population, and the advanced healthcare infrastructure. The presence of key manufacturers in the United States, as well as the increasing prevalence of the condition, are two of the primary reasons for market expansion. According to the AHA 2021, over 17% of middle-aged females and 34% of middle-aged men met the diagnostic criteria for obstructive sleep apnea in the United States. Furthermore, the high burden of obesity is expected to positively impact the market's growth. For instance, according to the Sleep Apnea Organization, in 2021, more than 30 million Americans suffered from sleep apnea, and 80% of moderate-to-severe sleep apnea cases were undiagnosed. The condition affects more than 20% of obese people every year.
Moreover, strategic developments by the leading players are one of the major factors driving the growth of the oral sleep apnea market. For instance, in May 2022, ProSomnus Holdings Inc. and Lakeshore Acquisition merged under the definitive business combination agreement to become ProSomnus, Inc. The deal is expected to accelerate the development and commercialization of ProSomnus' oral appliance therapy devices.
In October 2022, Panthera Dental signed an exclusive distribution agreement with MK1 Dental-Attachment GmbH to expand the oral sleep apnea and dental products offering in the United States and Canada. In May 2022, Panthera Dental, in collaboration with Medit Corp., announced the creation of a completely digital workflow to provide world-class custom-made snoring and obstructive sleep apnea management through an integrated digital workflow. Further, these continuous developments in the region are anticipated to drive the growth of the market.
Therefore, owing to the aforesaid factors, the growth of the studied market is anticipated in the North American region.
